Pilot Trial Demonstrates Feasibility of Prolonged Nightly Fasting for Men on Androgen Deprivation Therapy — Implications for Metabolic Health

References

1. 1.Grossmann, M., & Zajac, J. D. (2011). Management of side effects of androgen deprivation therapy. Endocrinology and Metabolism Clinics, 40(3), 655-671. https://doi.org/10.1016/j.ecl.2011.05.004
2. 2.Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006). Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology, 24(27), 4448-4456. https://doi.org/10.1200/JCO.2006.06.2497
3. 3.Longo, V. D., & Mattson, M. P. (2014). Fasting: molecular mechanisms and clinical applications. Cell Metabolism, 19(2), 181-192. https://doi.org/10.1016/j.cmet.2013.12.008
4. 4.Nguyen, P. L., Alibhai, S. M., Basaria, S., D'Amico, A. V., Kantoff, P. W., Keating, N. L., ... & Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European Urology, 67(5), 825-836. https://doi.org/10.1016/j.eururo.2014.07.010
5. 5.Pharmaceutical Benefits Scheme. (2024). PBS Schedule - Prostate Cancer Treatments. Australian Government Department of Health. https://www.pbs.gov.au/
6. 6.Thomas Jefferson University. (2024). A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled. ClinicalTrials.gov. NCT07462403. https://clinicaltrials.gov/study/NCT07462403